Clinical Trial Update: Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating tetracycline for Epidermolysis Bullosa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa

Drugs mentioned

• tetracycline (tetracycline)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Epidermolysis Bullosa | Phase 4 | Status: WITHDRAWN